Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Study of omeprazole-gamma-cyclodextrin complexation in the solid state.

M J Arias1, J R Moyano, P Muñoz

  • 1Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Seville, Spain. mjarias@fafar.us.es

Drug Development and Industrial Pharmacy
|March 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Infectious bacterial symphysitis (purulent infection of the pubic symphysis) in a urological setting-a descriptive study and treatment algorithm].

Urologie (Heidelberg, Germany)·2025
Same author

Congenital cranial fasciitis of the ethmoid bone with extensive intracranial and facial involvement: a case report and review of the literature.

International journal of oral and maxillofacial surgery·2025
Same author

Erratum: Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at sqrt[s_{NN}]=200  GeV [Phys. Rev. Lett. 116, 122301 (2016)].

Physical review letters·2025
Same author

<i>Pluteus arizonicus,</i> a new species from Western North America.

Fungal systematics and evolution·2025
Same author

<i>Macrolepiota macilenta</i> and <i>M. pallida</i>, two new species from North America.

Fungal systematics and evolution·2025
Same author

Multidisciplinary consensus-based statement on the current role of middle meningeal artery embolization (MMAE) in chronic SubDural hematoma (cSDH).

Brain & spine·2024

This study explored forming omeprazole (OME) and gamma-cyclodextrin (gamma-CD) inclusion complexes using various methods. The comprecipitation technique yielded the fastest drug release, enhancing omeprazole dissolution.

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science

Background:

  • Omeprazole (OME) is a widely used proton pump inhibitor with limited aqueous solubility.
  • Cyclodextrins, particularly gamma-cyclodextrin (gamma-CD), are known to form inclusion complexes with drugs, potentially improving their physicochemical properties.

Purpose of the Study:

  • To evaluate the formation of omeprazole-gamma-cyclodextrin inclusion complexes using different preparation methods.
  • To characterize the resulting inclusion compounds and assess their impact on omeprazole's dissolution rate.

Main Methods:

  • Preparation of inclusion complexes via kneading, spray-drying, coprecipitation, and freeze-drying.
  • Characterization using differential scanning calorimetry (DSC), infrared spectroscopy, X-ray powder diffractometry (PXRD), and scanning electron microscopy (SEM).

Related Experiment Videos

  • Dissolution rate studies to compare drug release from different formulations.

    • Main Results:

    • All evaluated methods successfully produced true inclusion compounds of omeprazole and gamma-cyclodextrin.
    • PXRD and SEM provided insights into the crystallinity and surface morphology of the obtained solid phases.
    • A significant increase in the release rate of omeprazole was observed for all inclusion complexes compared to the free drug.
    • The coprecipitated product exhibited the highest dissolution rate among all prepared solid phases.

    Conclusions:

    • Formation of omeprazole-gamma-cyclodextrin inclusion complexes can be achieved through various techniques.
    • The coprecipitation method is most effective in enhancing the dissolution rate of omeprazole.
    • These findings suggest that complexation with gamma-CD is a viable strategy to improve omeprazole's bioavailability.